Cargando…

Plasma omentin levels are inversely associated with atherosclerosis in type 2 diabetes patients with increased plasma adiponectin levels: a cross-sectional study

BACKGROUND: Omentin and adiponectin are among the anti-inflammatory and anti-atherogenic adipokines that have potentially beneficial effects on cardiovascular disorders. Recent studies indicate a paradoxical relationship between adiponectin and cardiovascular mortality across many clinical settings...

Descripción completa

Detalles Bibliográficos
Autores principales: Nishimura, Masami, Morioka, Tomoaki, Hayashi, Mariko, Kakutani, Yoshinori, Yamazaki, Yuko, Kurajoh, Masafumi, Mori, Katsuhito, Fukumoto, Shinya, Shioi, Atsushi, Shoji, Tetsuo, Inaba, Masaaki, Emoto, Masanori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6894467/
https://www.ncbi.nlm.nih.gov/pubmed/31805941
http://dx.doi.org/10.1186/s12933-019-0973-3
_version_ 1783476392910913536
author Nishimura, Masami
Morioka, Tomoaki
Hayashi, Mariko
Kakutani, Yoshinori
Yamazaki, Yuko
Kurajoh, Masafumi
Mori, Katsuhito
Fukumoto, Shinya
Shioi, Atsushi
Shoji, Tetsuo
Inaba, Masaaki
Emoto, Masanori
author_facet Nishimura, Masami
Morioka, Tomoaki
Hayashi, Mariko
Kakutani, Yoshinori
Yamazaki, Yuko
Kurajoh, Masafumi
Mori, Katsuhito
Fukumoto, Shinya
Shioi, Atsushi
Shoji, Tetsuo
Inaba, Masaaki
Emoto, Masanori
author_sort Nishimura, Masami
collection PubMed
description BACKGROUND: Omentin and adiponectin are among the anti-inflammatory and anti-atherogenic adipokines that have potentially beneficial effects on cardiovascular disorders. Recent studies indicate a paradoxical relationship between adiponectin and cardiovascular mortality across many clinical settings including type 2 diabetes. In this study, we characterized the clinical features of type 2 diabetes patients with increased adiponectin levels and examined the association between omentin and atherosclerosis in those patients. METHODS: The subjects were 413 patients with type 2 diabetes. Fasting plasma omentin and total adiponectin levels were measured by enzyme-linked immunosorbent assay. The intima-media thickness (IMT) of the common carotid artery was measured by ultrasonography. The subjects were stratified according to the median value of plasma adiponectin. RESULTS: In high-adiponectin group, omentin levels were higher, while IMT tended to be greater than those in low-adiponectin group. The high-adiponectin group also exhibited older age, higher systolic blood pressure, lower kidney function, body mass index, and insulin resistance index compared to the low-adiponectin group. Multivariate analysis revealed that omentin levels were independently and negatively associated with IMT in high-adiponectin group, but not in low-adiponectin group, after adjusting for adiponectin levels and traditional cardiovascular risk factors. On the other hand, adiponectin levels were not significantly associated with IMT in either group. CONCLUSIONS: Plasma omentin levels are inversely associated with IMT in type 2 diabetes patients with increased adiponectin levels and multiple cardiovascular risk factors. This study suggests a protective role of omentin against atherosclerosis in type 2 diabetes patients, which is potentially influenced by adiponectin level and cardiovascular risk status.
format Online
Article
Text
id pubmed-6894467
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-68944672019-12-11 Plasma omentin levels are inversely associated with atherosclerosis in type 2 diabetes patients with increased plasma adiponectin levels: a cross-sectional study Nishimura, Masami Morioka, Tomoaki Hayashi, Mariko Kakutani, Yoshinori Yamazaki, Yuko Kurajoh, Masafumi Mori, Katsuhito Fukumoto, Shinya Shioi, Atsushi Shoji, Tetsuo Inaba, Masaaki Emoto, Masanori Cardiovasc Diabetol Original Investigation BACKGROUND: Omentin and adiponectin are among the anti-inflammatory and anti-atherogenic adipokines that have potentially beneficial effects on cardiovascular disorders. Recent studies indicate a paradoxical relationship between adiponectin and cardiovascular mortality across many clinical settings including type 2 diabetes. In this study, we characterized the clinical features of type 2 diabetes patients with increased adiponectin levels and examined the association between omentin and atherosclerosis in those patients. METHODS: The subjects were 413 patients with type 2 diabetes. Fasting plasma omentin and total adiponectin levels were measured by enzyme-linked immunosorbent assay. The intima-media thickness (IMT) of the common carotid artery was measured by ultrasonography. The subjects were stratified according to the median value of plasma adiponectin. RESULTS: In high-adiponectin group, omentin levels were higher, while IMT tended to be greater than those in low-adiponectin group. The high-adiponectin group also exhibited older age, higher systolic blood pressure, lower kidney function, body mass index, and insulin resistance index compared to the low-adiponectin group. Multivariate analysis revealed that omentin levels were independently and negatively associated with IMT in high-adiponectin group, but not in low-adiponectin group, after adjusting for adiponectin levels and traditional cardiovascular risk factors. On the other hand, adiponectin levels were not significantly associated with IMT in either group. CONCLUSIONS: Plasma omentin levels are inversely associated with IMT in type 2 diabetes patients with increased adiponectin levels and multiple cardiovascular risk factors. This study suggests a protective role of omentin against atherosclerosis in type 2 diabetes patients, which is potentially influenced by adiponectin level and cardiovascular risk status. BioMed Central 2019-12-05 /pmc/articles/PMC6894467/ /pubmed/31805941 http://dx.doi.org/10.1186/s12933-019-0973-3 Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Original Investigation
Nishimura, Masami
Morioka, Tomoaki
Hayashi, Mariko
Kakutani, Yoshinori
Yamazaki, Yuko
Kurajoh, Masafumi
Mori, Katsuhito
Fukumoto, Shinya
Shioi, Atsushi
Shoji, Tetsuo
Inaba, Masaaki
Emoto, Masanori
Plasma omentin levels are inversely associated with atherosclerosis in type 2 diabetes patients with increased plasma adiponectin levels: a cross-sectional study
title Plasma omentin levels are inversely associated with atherosclerosis in type 2 diabetes patients with increased plasma adiponectin levels: a cross-sectional study
title_full Plasma omentin levels are inversely associated with atherosclerosis in type 2 diabetes patients with increased plasma adiponectin levels: a cross-sectional study
title_fullStr Plasma omentin levels are inversely associated with atherosclerosis in type 2 diabetes patients with increased plasma adiponectin levels: a cross-sectional study
title_full_unstemmed Plasma omentin levels are inversely associated with atherosclerosis in type 2 diabetes patients with increased plasma adiponectin levels: a cross-sectional study
title_short Plasma omentin levels are inversely associated with atherosclerosis in type 2 diabetes patients with increased plasma adiponectin levels: a cross-sectional study
title_sort plasma omentin levels are inversely associated with atherosclerosis in type 2 diabetes patients with increased plasma adiponectin levels: a cross-sectional study
topic Original Investigation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6894467/
https://www.ncbi.nlm.nih.gov/pubmed/31805941
http://dx.doi.org/10.1186/s12933-019-0973-3
work_keys_str_mv AT nishimuramasami plasmaomentinlevelsareinverselyassociatedwithatherosclerosisintype2diabetespatientswithincreasedplasmaadiponectinlevelsacrosssectionalstudy
AT moriokatomoaki plasmaomentinlevelsareinverselyassociatedwithatherosclerosisintype2diabetespatientswithincreasedplasmaadiponectinlevelsacrosssectionalstudy
AT hayashimariko plasmaomentinlevelsareinverselyassociatedwithatherosclerosisintype2diabetespatientswithincreasedplasmaadiponectinlevelsacrosssectionalstudy
AT kakutaniyoshinori plasmaomentinlevelsareinverselyassociatedwithatherosclerosisintype2diabetespatientswithincreasedplasmaadiponectinlevelsacrosssectionalstudy
AT yamazakiyuko plasmaomentinlevelsareinverselyassociatedwithatherosclerosisintype2diabetespatientswithincreasedplasmaadiponectinlevelsacrosssectionalstudy
AT kurajohmasafumi plasmaomentinlevelsareinverselyassociatedwithatherosclerosisintype2diabetespatientswithincreasedplasmaadiponectinlevelsacrosssectionalstudy
AT morikatsuhito plasmaomentinlevelsareinverselyassociatedwithatherosclerosisintype2diabetespatientswithincreasedplasmaadiponectinlevelsacrosssectionalstudy
AT fukumotoshinya plasmaomentinlevelsareinverselyassociatedwithatherosclerosisintype2diabetespatientswithincreasedplasmaadiponectinlevelsacrosssectionalstudy
AT shioiatsushi plasmaomentinlevelsareinverselyassociatedwithatherosclerosisintype2diabetespatientswithincreasedplasmaadiponectinlevelsacrosssectionalstudy
AT shojitetsuo plasmaomentinlevelsareinverselyassociatedwithatherosclerosisintype2diabetespatientswithincreasedplasmaadiponectinlevelsacrosssectionalstudy
AT inabamasaaki plasmaomentinlevelsareinverselyassociatedwithatherosclerosisintype2diabetespatientswithincreasedplasmaadiponectinlevelsacrosssectionalstudy
AT emotomasanori plasmaomentinlevelsareinverselyassociatedwithatherosclerosisintype2diabetespatientswithincreasedplasmaadiponectinlevelsacrosssectionalstudy